Brett A. Thibodeaux

889 total citations
30 papers, 724 citations indexed

About

Brett A. Thibodeaux is a scholar working on Infectious Diseases, Ophthalmology and Molecular Biology. According to data from OpenAlex, Brett A. Thibodeaux has authored 30 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 12 papers in Ophthalmology and 10 papers in Molecular Biology. Recurrent topics in Brett A. Thibodeaux's work include Ocular Infections and Treatments (12 papers), Bacterial biofilms and quorum sensing (8 papers) and Intraocular Surgery and Lenses (7 papers). Brett A. Thibodeaux is often cited by papers focused on Ocular Infections and Treatments (12 papers), Bacterial biofilms and quorum sensing (8 papers) and Intraocular Surgery and Lenses (7 papers). Brett A. Thibodeaux collaborates with scholars based in United States, Netherlands and China. Brett A. Thibodeaux's co-authors include Richard J. O’Callaghan, Mary E. Marquart, Armando R. Caballero, Joseph J. Dajcs, Dalia O. Girgis, John T. Roehrig, Jo Rae Wright, Ruud A. W. Veldhuizen, Jaret Malloy and Carol D. Blair and has published in prestigious journals such as Journal of Biological Chemistry, Journal of the American College of Cardiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Brett A. Thibodeaux

29 papers receiving 708 citations

Peers

Brett A. Thibodeaux
Armando R. Caballero United States
Paulo J. M. Bispo United States
David McKenney United States
M A Edelstein United States
Indre Budvytiene United States
Ali Abdul Lattif United States
Armando R. Caballero United States
Brett A. Thibodeaux
Citations per year, relative to Brett A. Thibodeaux Brett A. Thibodeaux (= 1×) peers Armando R. Caballero

Countries citing papers authored by Brett A. Thibodeaux

Since Specialization
Citations

This map shows the geographic impact of Brett A. Thibodeaux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brett A. Thibodeaux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brett A. Thibodeaux more than expected).

Fields of papers citing papers by Brett A. Thibodeaux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brett A. Thibodeaux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brett A. Thibodeaux. The network helps show where Brett A. Thibodeaux may publish in the future.

Co-authorship network of co-authors of Brett A. Thibodeaux

This figure shows the co-authorship network connecting the top 25 collaborators of Brett A. Thibodeaux. A scholar is included among the top collaborators of Brett A. Thibodeaux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brett A. Thibodeaux. Brett A. Thibodeaux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boyd, Justin D., Shixia Wang, Hsiao‐Wen Lin, et al.. (2025). Preclinical characterization of an active immunotherapy targeting calcitonin gene-related peptide. Communications Medicine. 5(1). 145–145.
2.
Lu, Hanxin, Maggie Lewis, Brett A. Thibodeaux, et al.. (2024). VXX-401, a novel anti-PCSK9 vaccine, reduces LDL-C in cynomolgus monkeys. Journal of Lipid Research. 65(2). 100497–100497. 15 indexed citations
3.
Calvert, Amanda E., Joseph Piper, Brett A. Thibodeaux, et al.. (2016). A humanized monoclonal antibody neutralizes yellow fever virus strain 17D-204 in vitro but does not protect a mouse model from disease. Antiviral Research. 131. 92–99. 7 indexed citations
4.
Julander, Justin G., Brett A. Thibodeaux, John D. Morrey, John T. Roehrig, & Carol D. Blair. (2014). Humanized monoclonal antibody 2C9-cIgG has enhanced efficacy for yellow fever prophylaxis and therapy in an immunocompetent animal model. Antiviral Research. 103. 32–38. 12 indexed citations
5.
Thibodeaux, Brett A., et al.. (2012). A small animal peripheral challenge model of yellow fever using interferon-receptor deficient mice and the 17D-204 vaccine strain. Vaccine. 30(21). 3180–3187. 39 indexed citations
6.
Thibodeaux, Brett A., Armando R. Caballero, Mary E. Marquart, Jan Tommassen, & Richard J. O’Callaghan. (2007). Corneal Virulence ofPseudomonas aeruginosaElastase B and Alkaline Protease Produced byPseudomonas putida. Current Eye Research. 32(4). 373–386. 33 indexed citations
7.
Caballero, Armando R., et al.. (2006). Effectiveness of Fluoroquinolones Against Mycobacterium abscessus In Vivo. Current Eye Research. 31(1). 23–29. 6 indexed citations
8.
Thibodeaux, Brett A., Armando R. Caballero, Joseph J. Dajcs, et al.. (2005). Pseudomonas aeruginosaProtease IV: A Corneal Virulence Factor of Low Immunogenicity. Ocular Immunology and Inflammation. 13(2-3). 169–182. 13 indexed citations
9.
Guerra, Aldo Benjamin, et al.. (2005). Comparison of Bacterial Inoculation and Transcutaneous Oxygen Tension in the Rabbit S1Perforator and Latissimus Dorsi Musculocutaneous Flaps. Journal of Reconstructive Microsurgery. 21(2). 137–143. 21 indexed citations
10.
Malloy, Jaret, Ruud A. W. Veldhuizen, Brett A. Thibodeaux, Richard J. O’Callaghan, & Jo Rae Wright. (2004). Pseudomonas aeruginosaprotease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions. American Journal of Physiology-Lung Cellular and Molecular Physiology. 288(2). L409–L418. 103 indexed citations
11.
Thibodeaux, Brett A., Joseph J. Dajcs, Armando R. Caballero, et al.. (2004). Quantitative comparison of fluoroquinolone therapies of experimental Gram-negative bacterial keratitis. Current Eye Research. 28(5). 337–342. 22 indexed citations
12.
Dajcs, Joseph J., et al.. (2004). Effectiveness of Ciprofloxacin, Levofloxacin, or Moxifloxacin for Treatment of Experimental Staphylococcus aureus Keratitis. Antimicrobial Agents and Chemotherapy. 48(6). 1948–1952. 57 indexed citations
13.
Marquart, Mary E., et al.. (2003). Identification of the Active Site Residues of Pseudomonas aeruginosa Protease IV. Journal of Biological Chemistry. 278(4). 2549–2553. 24 indexed citations
14.
Marquart, Mary E., Joseph J. Dajcs, Armando R. Caballero, Brett A. Thibodeaux, & Richard J. O’Callaghan. (2003). Calcium and magnesium enhance the production of Pseudomonas aeruginosa protease IV, a corneal virulence factor. Medical Microbiology and Immunology. 194(1-2). 39–45. 18 indexed citations
15.
Thibodeaux, Brett A., et al.. (2002). Pseudomonas Protease And Corneal Virulence. Investigative Ophthalmology & Visual Science. 43(13). 1596–1596. 1 indexed citations
16.
Dajcs, Joseph J., Brett A. Thibodeaux, Dalia O. Girgis, & Richard J. O’Callaghan. (2002). Corneal Virulence of Staphylococcus aureus in an Experimental Model of Keratitis. DNA and Cell Biology. 21(5-6). 375–382. 46 indexed citations
17.
Moreau, Judy M., Emma B.H. Hume, Joseph J. Dajcs, et al.. (2002). Effectiveness of Mupirocin and Polymyxin B in Experimental Staphylococcus aureus, Pseudomonas aeruginosa, and Serratia marcescens Keratitis. Cornea. 21(8). 807–811. 15 indexed citations
18.
Dajcs, Joseph J., et al.. (2002). Immunity to lysostaphin and its therapeutic value for ocular MRSA infections in the rabbit.. PubMed. 43(12). 3712–6. 41 indexed citations
19.
Dajcs, Joseph J., Judy M. Moreau, David W. Stroman, et al.. (2001). The effectiveness of tobramycin and Ocuflox® in a prophylaxis model of Staphylococcus keratitis. Current Eye Research. 23(1). 60–63. 9 indexed citations
20.
Dajcs, Joseph J., Brett A. Thibodeaux, Emma B.H. Hume, et al.. (2001). Lysostaphin is effective in treating methicillin-resistant Staphylococcus aureus endophthalmitis in the rabbit. Current Eye Research. 22(6). 451–457. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026